CPT code 59015 designates chorionic villus sampling (CVS), an invasive prenatal diagnostic procedure to obtain placental tissue for chromosomal analysis. CVS is performed transvaginally or transabdominally and is clinically important for early detection of chromosomal abnormalities, influencing pregnancy management and genetic counseling. Nationally, the code is relevant across public and private payers due to its clinical implications and utilization in prenatal care.

Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical service, typical sites of service, and the procedural context for billing. The publication provides benchmarks where available, outlines common billing modifiers and administrative considerations, and summarizes policy and coverage themes affecting authorization, documentation, and medical necessity for CVS. Additionally, the resource highlights coding relationships and potential billing scenarios relevant to prenatal diagnostic workflows.

This summary is intended for clinicians, billing professionals, and policy analysts seeking a national-level reference for coding, coverage considerations, and clinical context related to CPT code 59015. Data not available in the input will be noted in the detailed sections.